ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics, such ADCs, ISACs and DACs, to address significant unmet need in oncology, immuno-oncology and immunology. ImmunoBiochem’s novel bioconjugates for precision immunology utilize unique antibody targets for the delivery of potent protein degrader payloads modulating select immunological pathways in specific cell subtypes in the desirable context in relevant autoimmune disorders such as to avoid broad side-effects of existing biologics and small molecule therapeutics.

ImmunoBiochem Corporation logo



Event details

Date: June 3 - 6, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


42 in total